Primary Site >> Biliary tract Cancer

Gene >> BCL2L1

Journal: Hepatology. 1997 Oct;26(4):884-90.
Title: Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line.
Author: Harnois, D M|Que, F G|Celli, A|LaRusso, N F|Gores, G J
PMID: 9328309
Journal: Pancreatology. 2001;1(3):254-62.
Title: Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
Author: Evans, J D|Cornford, P A|Dodson, A|Greenhalf, W|Foster, C S|Neoptolemos, J P
PMID: 12120204
Journal: Gut. 2002 Oct;51(4):556-61.
Title: Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.
Author: Okaro, A C|Fennell, D A|Corbo, M|Davidson, B R|Cotter, F E
PMID: 12235080
Journal: Hepatology. 2004 Apr;39(4):1028-37.
Title: Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Author: Zhang, Zichen|Lai, Guan-Hua|Sirica, Alphonse E
PMID: 15057907
Journal: Cancer Res. 2004 May 15;64(10):3517-24.
Title: Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Author: Taniai, Makiko|Grambihler, Annette|Higuchi, Hajime|Werneburg, Nate|Bronk, Steve F|Farrugia, Daniel J|Kaufmann, Scott H|Gores, Gregory J
PMID: 15150106
Journal: Cancer Res. 2005 Jul 15;65(14):6312-20.
Title: Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Author: Kim, Jong-Hyun|Liu, Lan|Lee, Seung-Ok|Kim, Yong-Tae|You, Kyung-Ran|Kim, Dae-Ghon
PMID: 16024633
Journal: World J Gastroenterol. 2010 Jan 14;16(2):156-66.
Title: Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
Author: Wolf, Samuel|Lorenz, Jana|Mossner, Joachim|Wiedmann, Marcus
PMID: 20066734
Journal: World J Gastroenterol. 2010 May 21;16(19):2362-70.
Title: Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Author: Buranrat, Benjaporn|Prawan, Auemduan|Kukongviriyapan, Upa|Kongpetch, Sarinya|Kukongviriyapan, Veerapol
PMID: 20480521
Journal: Cancer Chemother Pharmacol. 2011 Mar;67(3):557-67.
Title: The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
Author: Romani, Antonello A|Desenzani, Silvia|Morganti, Marina M|Baroni, Maria Cristina|Borghetti, Angelo F|Soliani, Paolo
PMID: 20473610
Journal: Surgery. 2011 Jul;150(1):25-31.
Title: Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.
Author: Zhou, Li|He, Xiao-Dong|Yu, Jian-Chun|Zhou, Rou-Li|Shan, Yi|Rui, Jing-An
PMID: 21429547
Journal: Acta Pharmacol Sin. 2013 Feb;34(2):301-8.
Title: Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-kappaB.
Author: Zhang, Dian-cai|Liu, Jin-long|Ding, Yong-bin|Xia, Jian-guo|Chen, Guo-yu
PMID: 23274410
Journal: Biochimie. 2014 Jun;101:183-91.
Title: Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-kappaB pathway.
Author: Li, Wenjiao|Li, Ming|Su, Xinhui|Qin, Liping|Miao, Mengmeng|Yu, Chundong|Shen, Yuemao|Luo, Qi|Chen, Qiang
PMID: 24486723
Journal: BMC Cancer. 2014 Oct 25;14:783.
Title: FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
Author: Lu, Zhaoyang|Wang, Jiabei|Zheng, Tongsen|Liang, Yingjian|Yin, Dalong|Song, Ruipeng|Pei, Tiemin|Pan, Shangha|Jiang, Hongchi|Liu, Lianxin
PMID: 25344679
Journal: Oncol Lett. 2016 Jan;11(1):474-480. Epub 2015 Nov 6.
Title: The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine.
Author: Li, Qiwei|Yin, Xiaobin|Wang, Wei|Zhan, Ming|Zhao, Benpeng|Hou, Zhaoyuan|Wang, Jian
PMID: 26870236
Journal: Tumour Biol. 2016 Aug;37(8):11495-507.
Title: Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
Author: Samatiwat, Papavee|Prawan, Auemduan|Senggunprai, Laddawan|Kukongviriyapan, Upa|Kukongviriyapan, Veerapol
PMID: 27015836
Journal: Oncotarget. 2016 Jun 7;7(23):34617-29.
Title: FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.
Author: Wang, Wei|Zhan, Ming|Li, Qi|Chen, Wei|Chu, Huiling|Huang, Qihong|Hou, Zhaoyuan|Man, Mohan|Wang, Jian
PMID: 27127878